Retrorectal tumor: is biopsy risky?
A 55-year-old white man with an extensive retrorectal tumor died after transrectal needle biopsy. The indications and methods for biopsy of tumors in this location are controversial and are not well delineated in the literature. When resection seems unlikely or risky, or if a neoplasm is suspected which could be treated by nonsurgical means, biopsy is indicated. Antibiotics with aerobic and anaerobic coverage should be given prophylactically. When CT scan or sigmoidoscopic findings suggest a necrotic tumor, the transrectal approach should be avoided.
D001706:Biopsy / Q000009:adverse effects*; D003015:Clostridium Infections / Q000209:etiology*; D003016:Clostridium perfringens; D006801:Humans; D008297:Male; D008875:Middle Aged; D012004:Rectal Neoplasms / Q000175:diagnosis*; D012512:Sarcoma, Ewing / Q000175:diagnosis*; D012772:Shock, Septic / Q000209:etiology*